Anuncio
Anuncio
DMAAU
D
Drugs Made In America Acquisition Corp. Units
10.53
USDPatrocinado
+0.01
+0.10%
08 ene, 15:58 UTC -5
Cerrado
Post-mercado
10.53
0.00
0.00%
Informes de beneficios de DMAAU
Ratio de Sorpresa Positivo
Sin datos disponibles para DMAAU
%
Próximo informe
Fecha del próximo informe
18 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/--
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/--
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/--
Drugs Made In America Acquisition Corp. Units earnings per share and revenue
On 17 nov 2025, DMAAU reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
What were Drugs Made In America Acquisition Corp. Units's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Drugs Made In America Acquisition Corp. Units reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Drugs Made In America Acquisition Corp. Units's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Drugs Made In America Acquisition Corp. Units expected to report next?
The next earning report is scheduled for 18 mar 2026.
What are the forecasts for Drugs Made In America Acquisition Corp. Units's next earnings report?
Based on --
analistas, Drugs Made In America Acquisition Corp. Units is expected to report EPS of -- and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio